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ABSTRACT Troponin C (TnC) belongs to the superfamily of EF-hand (helix–loop–helix) Ca21-binding proteins and is an
essential component of the regulatory thin ﬁlament complex. In a patient diagnosed with idiopathic dilated cardiomyopathy, we
identiﬁed two novel missense mutations localized in the regulatory Ca21-binding Site II of TnC, TnC(E59D,D75Y). Expression of
recombinant TnC(E59D,D75Y) in isolated rat cardiomyocytes induced a marked decrease in contractility despite normal intracellular
calcium homeostasis in intact cardiomyocytes and resulted in impaired myoﬁlament calcium responsiveness in Triton-
permeabilized cardiomyocytes. Expression of the individual mutants in cardiomyocytes showed that TnCD75Y was able to
recapitulate the TnC(E59D,D75Y) phenotype, whereas TnCE59D was functionally benign. Force-pCa relationships in TnC(E59D,D75Y)
reconstituted rabbit psoas ﬁbers and ﬂuorescence spectroscopy of TnC(E59D,D75Y) labeled with 2-[(49-iodoacetamide)-aniline]-
naphthalene-6-sulfonic acid showed a decrease in myoﬁlament Ca21 sensitivity and Ca21 binding afﬁnity, respectively.
Furthermore, computational analysis of TnC showed the Ca21-binding pocket as an active region of concerted motions, which
are decreasedmarkedly bymutation D75Y.We conclude that D75Y interferes with proper concertedmotions within the regulatory
Ca21-binding pocket of TnC that hinders the relay of the thin ﬁlament calcium signal, thereby providing a primary stimulus for
impaired cardiomyocyte contractility. This in turn may trigger pathways leading to aberrant ventricular remodeling and ultimately a
dilated cardiomyopathy phenotype.
INTRODUCTION
The thin filament proteins, the troponins and tropomyosin,
are the regulatory elements that coordinate striated muscle
contraction (1,2). The troponin complex is composed of three
structurally and functionally distinct subunits: troponin C
(TnC) is the calcium binding subunit, troponin T (TnT) an-
chors the troponin complex to tropomyosin, and troponin I
(TnI) together with tropomyosin regulate accessibility of the
myosin binding sites on actin. During systole, binding of
calcium to the regulatory domain of TnC is the critical first
step that elicits a series of conformational changes in the
troponin complex to weaken the inhibitory action of TnI and
tropomyosin. This enables the myosin heads to bind to actin
and generate force. Cardiac and skeletal TnC both contain
four EF-hand or helix–loop–helix Ca21-binding motifs and
are numbered I–IV, although Site I at the N-terminus of
cardiac TnC (cNTnC) has been rendered inactive due to
nucleotide substitutions in the cardiac TnC gene (3). Binding
Sites III and IV at the C terminus of TnC are high affinity
Ca21/Mg21 binding sites and are always occupied by either
divalent cation under normal physiological conditions (4,5),
and are thought to play a role in TnC-TnI interaction (6). It is
Site II at cNTnC that acts as a Ca21-sensitive molecular switch
that on binding of calcium and subsequent interaction with TnI
induces a conformational change in cNTnC from the ‘closed’
to ‘open’ state that serves to propagate the signal along the thin
filaments to release inhibition, allowing actin-myosin inter-
action to occur (7,8). Given the crucial role of TnC in sensing
intracellular calcium levels and triggering the cardiac con-
tractile cycle, it is not surprising that cardiac TnC is among the
most highly conserved genes in vertebrate species (9).
Using molecular cloning and DNA sequencing techniques,
we identified two novel missense mutations, E59D and
D75Y, in cardiac TnC isolated from a patient diagnosed with
idiopathic dilated cardiomyopathy (IDCM), a disease of un-
known etiology characterized by ventricular dilatation and
contractile dysfunction. To our knowledge, these are the first
mutations identified in cardiac TnC that are localized in
regulatory Ca21-binding Site II. Binding of calcium in EF-
hand II of the 12 amino acid residue-loop involves six neg-
atively charged residues, localized in positions 1 (1x), 3
(1y), 5 (1z), 7 (y), 9 (x), and 12 (z) (3,10). Mutation
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D75Y, in particular, is located adjacent to the z coordinate
and could potentially interfere with normal calcium binding
and/or signal transduction.
In an effort to elucidate the functional relevance of the
missense mutations in the regulatory Ca21-binding domain
of TnC we adopted a systematic approach that combines
targeted expression/integration of recombinant mutant TnC
in cardiomyocytes and in vitro functional assessment, with
protein chemistry and computational analysis of the mu-
tant TnC structure. Adenoviral expression of recombinant
TnC(E59D,D75Y) in rat cardiomyocytes showed impaired cell
contractility (despite normal calcium homeostasis) and a
decrease in myofilament calcium responsiveness in electri-
cally stimulated intact cells and triton-permeabilized cells,
respectively. The functional TnC(E59D,D75Y) phenotype was
recapitulated with cells expressing recombinant TnCD75Y,
but not TnCE59D. Force-pCa relationships in rabbit psoas fi-
bers reconstituted with mutant TnC(E59D,D75Y) and fluores-
cence spectroscopy of IAANS-labeled TnC(E59D,D75Y) showed
a decrease in myofilament Ca21-sensitivity and Ca21-binding
affinity, respectively. Interestingly, normal mode analysis of
the Ca21-free form of TnC showed Ca21-binding Site II as an
active area of dynamic concerted motions that is markedly
reduced in the TnCD75Y mutant. Our study provides mech-
anistic insight into how a specific mutation in the regulatory
domain of TnC might alter calcium binding and signal trans-
mission with consequent myocyte contractile dysfunction.
MATERIALS AND METHODS
Identiﬁcation of two missense mutations in
cardiac TnC
Total RNA was isolated from;1 g of left ventricular tissue, isolated from a
patient diagnosed with IDCM, by the guanidium isothiocyanate method
(11). First strand cDNA was synthesized using AMV reverse transcriptase
(Invitrogen, Carlsbad, CA). A pair of oligonucleotide primers for synthesis of
the double-strand cDNA encoding human TnCwere constructed according to
the published cDNA sequence (12). The product of the first strand cDNA
reaction was then directly used in a PCR (polymerase chain reaction) with the
synthesized primer pair in the presence of Taq DNA polymerase. PCR
products were purified using 1% low melting point (LMP) agarose gel
(Gibco-BRL, Rockville, MD). The purified PCR products were cloned into a
TA cloning vector pCR 2.1 (Invitrogen) followed by the standard procedures
for transformation and propagation of the recombinant molecules in an
Escherichia coli host. The recombinant DNA molecules were then purified
and digested by the selected restriction enzymes. The digested cDNA was
again purified by LMP gel and subcloned into a pET-24 expression vector
(Novagen, La Jolla, CA) for sequence analyses. Sequenase Version 2.0 DNA
Sequencing Kit (USB, Cleveland, OH) was used to carry out DNA sequence
analysis. This procedure was repeated multiple times using different tissue
sections from the same heart, with the same result.
Mutagenesis and generation of
recombinant adenovirus
Human TnC (WT) cDNAwas subcloned into pGEM vector and mutagenesis
was carried out by PCR (Stratagene, La Jolla, CA) using oligonucleotide
59-AGCTGCAGGATATGATCGATG-39 for mutation E59D and 59-
GTGGACTTTTATGA GTTCC-39 for mutation D75Y (the mutation is in
bold and underlined). E59D/D75Y TnC was generated by consecutive mu-
tations of E59D and D75Y. TnC(E59D,D75Y), TnCE59D, TnCD75Y, and WT
TnC were subcloned into the pAdTrack-CMV shuttle vector using the Xba I
and Sal I sites (Qbiogene, Carlsbad, CA). Each vector construct contained
two independent CMV promoters, one for the cDNA insert and one for the
reporter gene, green fluorescent protein (GFP). The recombinant adenovirus
was generated through homologous recombination of the vector construct
with the pAdEasy-1 adenoviral plasmid in E. coli BJ5183 cells. The
recombinant products were amplified in HEK293 cells and expression levels
were confirmed by GFP fluorescence and Western blot detection. The re-
combinant adenoviruses were further amplified to high titer in HEK293 cells,
and band-purified by centrifugation in CsCl gradients to yield stock titers of
1–3 3 1010 plaque-forming-units (pfu)/ml.
Primary cultures of adult rat
ventricular myocytes
Ventricular myocytes were isolated from adult Wistar rats (200–250 g) using
a collagenase-based method, as previously described (13,14). Myocytes
were cultured on laminin-coated coverslips (microscopy and cell function
experiments) or p100 plates (Western blots andmass spectrometry) in serum-
free DMEM (Gibco-BRL) that contained in mM: 5 carnitine, 5 creatine,
10 taurine, 100 bromodeoxyuridine, 50 U/ml penicillin, and 50 mg/ml strep-
tomycin at 37C in 5% CO2. After 1 h the culture medium was removed and
myocytes were infected with WT TnC, mutant TnC, or lacZ adenovirus
diluted in culture media at a multiplicity of infection (MOI) of 100.Myocytes
not infected with virus were included as an adenoviral control. Culture media
was replaced at Day 1 and again at Day 3 postinfection. Myocytes were
studied at 4 days postinfection.
SDS PAGE and Western blot
At 4 days postinfection, myocytes were washed in Ca21-free solution (in
mM: 10 EGTA, 5.9 MgAc, 5.9 Na2ATP, 10 creatine phosphate, 40 imid-
azole, 70 K1-propionate, 5 NaN3, and 1 dithiothreitol). Myocytes were then
permeabilized in relaxing solution containing 1% Triton X-100 at 4C. After
50 min, the permeabilized myocytes were washed in relaxing solution,
harvested, and sonicated in 40 mM Tris-HCl buffer. The samples were sol-
ubilized in sample buffer heated at 70C for 5 min and 100 mg of protein
sample was loaded onto a 12% Bis-Tris gel (Invitrogen). For Western blot
analysis, proteins were transferred onto PVDFmembranes after SDS-PAGE.
Antibodies to TnC (1A2, Biodesign International Saco, ME), TnI and TnT
(C-19 and CT3, Santa Cruz Biotechnology, Santa Cruz, CA) and tropomy-
osin and actin (CH1 and AC-40, Sigma, St. Louis, MO) were used. To detect
GFP, intact myocytes were harvested in cell lysis solution, sonicated, and
solubilized in sample buffer heated to 95C for 5 min. Electrophoresis and
transfer was carried out as above and GFP protein content was determined by
immunoblot with GFP antibody (B2, Santa Cruz Biotechnology).
Mass spectrometry
Incorporation of adenoviral expressed TnC into the thin filament complex
was determined by MALDI-TOF/MS, as mutant TnC could not be distin-
guished from endogenous rat TnC by gel electrophoresis. Myocytes were
Triton-permeabilized to eliminate artifacts from unincorporated cytosolic
TnC, solubilized, and subjected to SDS-PAGE (see preceding section). The
gels were Coomassie-stained and the identified TnC gel band was excised,
minced, washed, reduced with DTT, alkylated with iodoacetamide, and di-
gested with AspN at pH 7.2 (15,16). The digested peptide fragments were
extracted from the gel pieces and desalted using ZiptipsC18 (Millipore,
Billerica, MA) according to manufacturer’s instruction and analyzed using
an Applied Biosystems/MDS-Sciex QStar Pulsar quadrupole/orthogonal
acceleration MALDI/TOF mass spectrometer with a nanospray source. To
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determine the percent of exogenous mutant TnC incorporation in rat car-
diomyocytes, a dilution series of a synthesized peptide covering the mutant
TnC region (73DFYEFLVMMVRCMK
86, mutation is underlined in bold)
and the peptide corresponding to control TnC (75DEFLVMMVRCMK
86)
was prepared and analyzed by mass spectrometry in triplicate. Peak intensity
(counts per second) and integrated peak areas in the mass spectra of multiple
digested peptide fragments were compared to the integrated area of the
known concentrations of synthesized peptides, to yield the percent incor-
poration of exogenous mutant-TnC.
Confocal ﬂuorescence microscopy
At 4 days postinfection, myocytes on coverslips were fixed in 3% para-
formaldehyde and 2% sucrose in PBS for 15min, permeabilized in 0.2%Triton
X-100 in PBS for 15 min, and blocked in 0.1% BSA in PBS for 1 h. Myocytes
were incubated with a monoclonal antibody to troponin C (1A2, Biodesign
International) for 1 h, washed in PBS, and incubated for 1 h with secondary
antibody conjugated to Cy5 (Alexa Fluor 647, Invitrogen-Molecular Probes,
Carlsbad, CA). After washing with PBS, myocytes were double immunola-
beled with monoclonal a-actinin antibody (EA53, Sigma) conjugated to
TRITC (Pierce, Rockford, IL). Stained preparations were mounted onto
slides with antifade (SlowFade, Molecular Probes) and analyzed for TRITC,
Cy5, and GFP fluorescence with a Leica TCS SP2 AOBS confocal laser
scanning microscope.
Myocyte function and fura-2 ﬂuorescence
Cell length and intracellular calcium were determined simultaneously by
video-edge detection and fura-2 fluorescence, respectively, as described
previously (13,14). The myocyte was perfused with 1.2 mM Ca21 Tyrode
solution at 37C and electrically stimulated at a rate of 3 Hz. Adenoviral
infection of the myocyte was confirmed by GFP fluorescence before data
acquisition. To minimize the chance of unequal GFP expression between
myocytes, the photon count due to GFP fluorescence was measured from a
fixed region of interest within all myocytes. Only myocytes with a photon
count in the range of;400 from the measured area were selected for further
study. After 10 min of baseline stabilization, myocyte contractility and fura-2
fluorescence were simultaneously recorded (see Fig. 3 A). Cell contractility
was assessed by % cell shortening, which is the ratio of twitch amplitude
(difference of end-diastolic and peak systolic cell lengths) to end-diastolic
cell length.
Myoﬁlament calcium responsiveness
The experimental procedure used to measure myofilament calcium respon-
siveness was modified from a protocol described previously (17). Briefly,
coverslips with myocytes at 4 days postinfection were affixed to a perfusion
chamber that was mounted on an inverted microscope (Nikon Diaphot epi-
fluorescence microscope). The myocytes were visualized using a Nikon340
(1.3 numerical aperture) oil-immersion fluorescence objective lens, and imaged
on a computer screen using a variable frame rate (60–240 Hz) CCD-camera, at
a sampling speed of 240 Hz. Sarcomere length was determined in real-time
using specialized acquisition and analysis software (IonOptix Corp., Milton,
MA). A single myocyte was selected and exclusively perfused with Ca21-free
Tyrode solution (in mM: 137 NaCl, 5.4 KCl, 0.5 MgCl2, 10 HEPES, 10 glu-
cose, pH 7.4). Adenoviral infection of the myocyte was confirmed by GFP
fluorescence. The myocyte was permeabilized subsequently in relaxing solu-
tion (in mM: 10 EGTA, 5.9 MgAc, 5.9 Na2ATP, 10 creatine phosphate, 40
imidazole, 70 K1-propionate, 5 NaN3, and 1 DTT) containing 1% Triton
X-100. After myocyte permeabilization (;2 min) myocytes were perfused
with relaxing solution (pCa9). After a 5-min stabilization period, the relaxing
solution was switched to a new pCa solution and sarcomere length shortening
continually monitored until it achieved steady state. The myocyte was re-
perfused subsequently with relaxing solution until slack sarcomere length was
achieved (see Fig. 4 A). This process was repeated for the various pCa solu-
tions. Responsiveness of the myofilaments to calcium was assessed by deter-
mining the relationship between the sarcomere length shortened to steady state
and its corresponding pCa (see Fig. 4 B).
Expression and puriﬁcation of recombinant TnC
Mutant TnC(E59D,D75Y) cDNA was generated from human cTnC cDNA by
site-directed mutagenesis (Quickchange, Stratagene) and subcloned into
pET-24a(1) (Novagen). WT or mutant cTnC constructs were transformed
into E. coli strain BL21 (DE3) lysogen (Novagen) for isopropyl-1-thio-b-D-
galactopyranoside (IPTG) induction of T7 RNA polymerase expression of
the target proteins. The IPTG-induced bacterial culture was harvested by
centrifugation and the pellet resuspended in a buffer solution containing
25 mM Tris, 2 mM EDTA, 8% sucrose, 0.2% Triton X-100, 100 mM PMSF,
10 mg lysozyme, at pH 8.0. The suspension was sonicated for 10 min and
centrifuged at 35,000 3 g for 1 h. The supernatant was dialyzed against an
alkaline buffer (in mM: 6000 urea, 50 Tris, 1 EGTA, 3 DTT, pH 8.0) and
loaded onto a DEAE-52 column (Whatman, Florham Park, NJ). Unpurified
recombinant protein was eluted from the column with a linear gradient of
0–400 mM KCl, pooled and extensively dialyzed against a Ca21 buffer (in
mM: 50 Tris, 300 KCl, 1 DTT, 5 CaCl2, at pH 7.5). The dialyzed protein was
chromatographed in a phenyl-Sepharose CL 4B (Sigma) column, washed
with 2 volumes of low salt Ca21 buffer, and eluted from the column with an
EGTA-buffer (in mM: 50 Tris, 100 KCl, 1 DTT, 20 EGTA, at pH 7.5). The
purified proteins were pooled and extensively dialyzed in ddH2O to remove
salts, lyophilized, and stored at 20C until use. Native skeletal TnC was
purified from ether powder of rabbit skeletal muscle as described previously
by Potter (18).
Force-pCa measurements
Single fibers from rabbit psoas muscle were isolated, chemically perme-
abilized in relaxing solution (see below) containing 1%Triton X-100, and the
ends fixed with glutaraldehyde and wrapped with aluminum foil T-clips for
mounting on a force measurement apparatus as described previously (19).
Fibers were attached to a Cambridge force transducer on one end and a
micromanipulator on the other, and the mechanical apparatus mounted on a
stage of an inverted microscope. Sarcomere length was measured by the
He-Ne laser diffraction method and set at ;2.5 mm. Solution changes were
achieved by rapidly immersing the fiber in individual custom-made cham-
bers containing various pCa activating solutions. The composition of re-
laxing (pCa 9.2) and Ca21 activating solutions were calculated and solutions
were made as described previously (19). Calcium activating solutions were
made by varying the amount of Ca(propionate)2 in Ca
21-free relaxing solu-
tion (in mM: 3 Mg ATP, 15 phosphocreatine, 15 EGTA, 83 MOPS, 1 Mg21,
133 Na1 1 K1, 25 U/ml creatine kinase). Ionic strength was 0.17 M and pH
was 7.0 at 20C. Extraction of endogenous skeletal TnC was achieved by
treating the permeabilized fibers with an extraction solution containing tri-
fluoperazine (in mM: 20 Tris, 5 EDTA, and 0.5 TFP, pH 7.8) for 5–12 min.
SDS-PAGE analysis of myofibril extracts confirmed that TnC was affected
primarily by the extraction reconstitution protocol (see Fig. 5 A). Endoge-
nous skeletal TnC extractionwas verified by a reduction in force at pCa 4.0 to
,2% of the pre-extraction value (see Fig. 5 B). Native skeletal TnC or re-
combinant TnC was incorporated in the TnC depleted fibers by incubation in
a relaxing solution containing 0.5 mg/ml TnC. Reconstitution of TnC was
considered complete when force at pCa 4.0 no longer increased with sub-
sequent incubations, typically 10 min of total incubation. Steady-state iso-
metric force was measured at each pCa, followed by slack measurement in
pCa 9.2 to obtain baseline tension (see Fig. 5 B). Active force was obtained
by subtracting total tension at each pCa from resting tension. The relative
force (F) versus pCa was determined for each experiment and a modified Hill
equation fitted to the data: F ¼ [Ca21]n/(Kn 1 [Ca21]n), with pCa at half-
maximal force calculated as pCa50 ¼ log(K), and n representing the slope
of the force relationship (Hill coefficient), a measure of cooperative activity.
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Fluorescence-pCa measurements
Fluorescent probe 2-((49-iodoacetamido)-anilino) naphthalene-6-sulfonic
acid (IAANS, Molecular Probes) was used to label cysteines 35 and 84 in the
purified recombinant TnC proteins and steady-state fluorescence measure-
ments was carried out using SPEX DM3000 fluorescence spectrometer as
described previously (20). Proteins labeled with IAANS were excited at 335
nm. In the Ca21 titration experiments, small aliquots of a standard CaCl2
solution were added to fluorescently labeled TnC. Changes in fluorescence
intensity induced by binding of Ca21 to IAANS labeled TnC was monitored
at the peak emission wavelength of 450 nm. Data were fitted using amodified
Hill equation: F/Fmax¼ [Ca21]n/(Kn1 [Ca21]n), where F is the fluorescence
change at a given [Ca21], Fmax is the maximal change in fluorescence, and K
is the binding constant (21). The pCa at half-maximal fluorescence (pCa50)
was calculated as pCa50 ¼ log(K).
Molecular dynamics simulations
Molecular dynamics (MD) simulations (6 ns) were carried out on both the
WT and D75Y forms of the Ca21-free N-lobe of troponin C (PDB entry:
1SPY) (22) at neutral pH and room temperature, 300 K with the AMBER
simulation package (23) and the all-atomic force field, parm99 (24). The
D75Y TnC mutant was generated by substituting Asp at position 75 in the
WT with Tyr using MOE (from Chemical Computing Group). The Cb co-
ordinates of Asp75 was kept in Tyr75, as a result, Tyr75 initially pointed
toward the solvent as Asp75. To keep the whole system neutral, counter ions
were added for both wild-type and D75Y-mutant. The TIP3P three-site rigid
water model was used to solvate the protein and counter ions (25). The
system was constructed using the periodic boundary conditions consisting of
the protein with 89 residues, counter ions, and water molecules that totaled
up to 21,926 atoms. The MD simulations were carried out in the N, P, and T
ensemble. The temperature and pressure of the system were regulated using
the Berendsen coupling algorithm with a coupling constant of 1.0 ps (26).
The particle mesh Ewald (PME) summation method was used to treat the
long-range electrostatic interactions (27). A 9 A˚ cutoff was used to limit the
direct space sum in PME. All bond lengths involving H atoms were con-
strained with the SHAKE algorithm (28). The time step was 1.5 fs. The
system was minimized 1000 steps to relax the bad contacts. After that,
the system was gradually heated to 300 K, and then equilibrated for 30 ps. In
the production run, the snapshots were saved every 1.5 ps.With this protocol,
a 6-ns production run was carried out for the wild-type and the mutant, re-
spectively. The secondary structure analysis was carried out using DSSP
(29). The van der Waals interaction energy between Tyr75 and helix N was
calculated with the ANALmodule in AMBER and averaged over the last 4.5
ns with an interval of 150 ps.
Normal mode analysis
Using the same starting structures as in the MD simulations, we carried out
the normal mode analysis on both the wild-type and the D75Y mutant. The
proteins were minimized using Newton-Raphson algorithm with distance
dependent dielectric constant to mimic solvent screening. The minimization
was stopped when the rms gradient was smaller than 0.00001 kcal/(mol A˚).
Finally, the normal mode analysis was carried out with nmode module in
Amber 7 package. The cross-correlation coefficient matrix was built from the
500 lowest frequency normal modes because the high frequency modes are
generally localized in proteins and therefore do not contribute to large con-
formational changes (30). The cross-correlation coefficient is defined as:
Cði; jÞ ¼ Dr~i  Dr~jjDr~ijjDr~jj;
whereDr~i andDr~j are the displacement vectors for Ca atoms of residues i and
j (31). If the motions of two atoms are perfectly correlated, the cross
correlation coefficient is 1, whereas1 indicates the strongest anti-correlated
motion, which is usually seen in protein unfolding.
Statistical analysis
Data are expressed as mean 6 SE. Statistical analysis was carried out using
GraphPad Prism 5 software. Student’s t-test was used to compare mean
values of WT versus TnC(E59D,D75Y). Group comparison was carried out
using one-way analysis of variance (ANOVA) with a Newman-Keuls mul-
tiple comparison post-hoc test. Analysis by two-way ANOVA compared
individual means by Bonferroni post-hoc test. A p-value of ,0.05 was
considered statistically significant.
RESULTS
Myoﬁlament incorporation of exogenously
expressed TnC
To assess the functional phenotype of the mutations, we
expressed recombinant WT and mutant TnC in rat cardiac
myocytes using standard adenoviral techniques. Myofila-
ment proteins are incorporated stoichiometrically into the
sarcomere lattice (32,33), and strong somatic TnC expression
should eventually lead to replacement of endogenous TnC in
the myofilaments during the process of normal protein
turnover. In Fig. 1 A, adenoviral co-expression of lacZ, WT,
or TnC(E59D,D75Y) with GFP at an MOI of 100 resulted in
.95% transfection efficiency of rat cardiomyocytes after 4
days, as determined by X-gal staining and GFP fluorescence.
Western blot analysis showed that concomitant GFP levels
were similar among the three groups (Fig. 1 A, lower panel).
We used mass spectrometry to distinguish the amount of
exogenously expressed TnC from endogenous TnC incor-
porated into the myofilaments of cardiomyocytes at 4 days
postinfection. The mass spectrometry pattern yielded iden-
tifiable peptide fragments, containing the D75Y mutation
(73DFYEFLVMMVRCMK
86) and the endogenous rat TnC
(75DEFLVMMVRCMK
86). Analysis of the mass spectrome-
try pattern showed that 35–40% of the endogenous TnC was
replaced by exogenous TnC(E59D,D75Y) as determined by peak
intensity (33.66 11.9%) and integrated area (37.66 10.6%).
Mutant TnC does not alter myoﬁlament
stoichiometry nor sarcomere structure
In striated muscle, myofilament architecture is highly regu-
lated and stoichiometry between the proteins strictly main-
tained. To address whether incorporation of exogenously
expressed TnC resulted in altered myofilament stoichiometry,
we examined myofilament protein levels in cardiomyocytes
by Western blot. Cardiomyocytes infected with WT or mu-
tant recombinant TnC adenovirus show comparable levels of
thin filament proteins: actin, troponin T, tropomyosin, tro-
ponin I, and troponin C (Fig. 1 B). We also did not detect any
differences in any of these proteins between uninfected cells
and cells infected with recombinant TnC adenovirus (data not
shown).
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We used confocal microscopy to examine if exogenous
TnC incorporation into the myofilaments altered sarcomere
ultra-structure (Fig. 2). Noninfected myocytes and myocytes
infected with WT and TnC(E59D,D75Y) adenovirus (confirmed
by GFP fluorescence) exhibit a periodic Z-line immunostain-
ing pattern of a-actinin (red fluorescence), which is charac-
teristic of all striated muscle. As expected, the TnC antibody
decorated the thin filaments as shown by immunofluorescence
between the Z-lines (cyan fluorescence). Confocal images for
myocytes infected with E59D and D75Y TnC showed similar
Z-line and TnC staining patterns (data not shown). These data
suggest that exogenous incorporation of TnC into the sarco-
mere (1) does not alter myofilament stoichiometry, and (2) has
no effect on the structural integrity of the sarcomere.
Mutation D75Y impairs cell function without
affecting calcium transients
To investigate the physiological relevance of TnC(E59D,D75Y)
incorporation into myofilaments, contractility and intracel-
lular calcium transients were measured in intact, electrically
stimulated cardiomyocytes. Co-expression of GFP facilitated
the identification of myocytes expressing recombinant TnC.
The fluorescent properties of GFP, however, complicate the
measurement of intracellular calcium indicator, fura-2, due to
spectral overlap (34). To circumvent this problem, we titrated
our infection protocol to yield a comparable level of GFP
expression in the WT and mutant TnC groups (Fig. 1 A). In
addition, myocytes with similar GFP fluorescence (Materials
andMethods) were selected to further minimize the chance of
unequal GFP expression between myocytes. This strategy
allowed us to differentiate between the functional conse-
quences of mutant TnC expression in the myocytes while
accounting for the influence of GFP expression. We found no
difference in % cell shortening (CS) between WT and lacZ-
GFP infected myocytes (WT¼ 3.26 0.4% vs. lacZ¼ 3.56
0.5%). Fig. 3 A shows typical tracings of CS and the intra-
cellular calcium transient from WT and E59D/D75Y TnC
myocytes, paced at a rate of 3 Hz and maintained at 37C.
The results for %CS and the fura-2 ratio are shown in Fig.
3 B. Expression of TnC(E59D,D75Y) resulted in a significant
reduction of %CS compared to WT (TnC(E59D,D75Y) ¼1.56
0.2% vs. WT ¼ 3.2 6 0.4%; p , 0.0001). The decrease in
%CS observed in TnCD75Y was comparable to that seen in
TnC(E59D,D75Y) (TnCD75Y ¼ 1.5 6 0.2%; p , 0.0005 vs.
WT), whereasmutation E59D had no effect (TnCE59D¼ 2.96
FIGURE 1 GFP and lacZ expression in adult rat ventricular myocytes at 4
days post adenoviral infection. (A) Bright field image of myocytes (left) with
galactosidase staining (middle), and GFP fluorescence (right), showing
robust adenoviral infection. Shown in the lower panel is a representative
Western blot with similar expression levels of GFP in lacZ, WT, and
TnC(E59D,D75Y) myocytes. GFP Western blot was repeated 4 times. (B)
Western blot analysis of actin, tropomyosin, TnT, TnI, and TnC in adeno-
viral infected myocytes show no difference in the levels of thin filament
proteins. The experiment was repeated 4 times for each antibody.
FIGURE 2 Confocal fluorescence images of adenoviral infected cardio-
myocytes. Intact cells were fixed and double labeled with an antibody to
TnC (cyan) and the Z-line protein a-actinin (red). Myocytes infected with
adenovirus have, in addition, a green fluorescence due to coexpression of
GFP (for comparison, GFP fluorescence was removed in the insets). The
a-actinin staining of the Z-lines exhibits a clear periodic pattern character-
istic of striated muscle, with TnC staining between the Z-lines. The bar at
lower magnification is 5 mm and the bar in the inset is 1 mm.
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0.2%; p ¼ NS vs. WT). Interestingly, the observed differ-
ences were Ca21-independent, because the fura-2 ratio
transients were similar among all groups. These data suggest
that impairment of contractility in TnC(E59D,D75Y) cells is at
the level of the myofilaments, as the intracellular calcium
transient was unaffected, and that the functional impairment
is mediated by mutation D75Y.
Mutation D75Y decreases myoﬁlament calcium
responsiveness in permeabilized cells
Co-expression of GFP allowed for easy identification of
adenoviral infected cells that were used subsequently for
measurement of myofilament calcium responsiveness. To
directly assess the state of the myofilament contractile ap-
paratus, selected myocytes were Triton-permeabilized and
the contractile response (SL shortening) of the skinnedmyocyte
to various calcium concentrations was determined, as de-
scribed previously (17). There was no difference in resting
SL at pCa9 between the groups (WT ¼ 1.818 6 0.003,
TnC(E59D,D75Y)¼ 1.8276 0.006, TnCE59D¼ 1.8256 0.005,
TnCD75Y ¼ 1.818 6 0.04; p ¼ NS). Fig. 4 A shows repre-
sentative SL tracings from WT and TnC(E59D,D75Y) cells
exposed to increasing calcium solutions, and Fig. 4 B shows
the relationship between the maximum SL change versus
pCa. The SL-pCa curves for noninfected cells, and cells in-
fected with lacZ-GFP were not different from WT (data not
shown). Incorporation of TnC(E59D,D75Y) resulted in marked
depression of myofilament calcium responsiveness at high
[Ca21] when compared to WT. Similar to the myocyte con-
tractility data, results from the single mutants showed that the
decrease in myofilament calcium responsiveness in TnCD75Y
is almost identical to that observed in TnC(E59D,D75Y),
whereas TnCE59D was not different from WT control. These
data suggest that the impaired myofilament calcium respon-
siveness in permeabilized TnC(E59D,D75Y) myocytes is me-
diated by mutation D75Y.
Myoﬁlament calcium sensitivity is decreased in
rabbit psoas ﬁbers reconstituted with
mutant TnC
The cell shortening-pCa assay does not control for sarcomere
length, which is an important determinant of myofilament
calcium sensitivity. Thus, to unequivocally address whether
the observed contractile phenotypes were due to a decrease in
myofilament calcium sensitivity, we measured the force-pCa
relationship in rabbit psoas fibers reconstituted with recom-
binant TnC. Endogenous skeletal TnC was extracted from
membrane permeabilized, fixed-end (sarcomere length ;2.5
mm), psoas fibers, and reconstituted with either purified na-
tive sTnC, WT cTnC, or TnC(E59D,D75Y). SDS-PAGE anal-
ysis of myofibril extracts confirmed that only TnC was
affected by the extraction/reconstitution procedure (Fig. 5 A).
Endogenous TnC extraction was verified by a reduction in
force at pCa 4.0 to,2% of the pre-extraction value (Fig. 5 B).
FIGURE 3 Cell shortening and calcium transients in
intact myocytes at 4 days post-adenoviral infection. (A)
Representative cell shortening and fura-2 calcium transients
of WT (black) and TnC(E59D,D75Y) (gray) cardiomyocytes.
(B) Bar graphs showing results for % cell shortening and
fura-2 ratio (systolic is top and diastolic is bottom of
floating bar). Cell shortening in TnC(E59D,D75Y) (black, n ¼
28) and TnCD75Y (cross-hatched, n ¼ 27) myocytes were
decreased significantly compared to WT (gray, n ¼ 22) or
TnCE59D (white, n ¼ 29), whereas intracellular calcium
was not different between the groups. Data expressed as
mean6 SE. *p, 0.05 TnC(E59D,D75Y) and TnCD75Y versus
WT and TnCE59D by one-way ANOVA, Newman-Keuls
post-hoc test.
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Reconstitution with WT cTnC resulted in;40% decrease in
maximal force when compared to fibers reconstituted with
native sTnC (Fig. 5 C). This is similar to what was reported
previously (35,36), and may simply reflect differences in the
interaction between cTnC and skeletal TnI and TnT as pre-
viously suggested (37). Reconstitution with TnC(E59D,D75Y)
resulted in an even greater decrease in maximal force,;75%
compared to sTnC (;50% compared to reconstituted WT
cTnC). The force-pCa relations were normalized and fitted to
a general Hill equation. In Fig. 6 A, TnC(E59D,D75Y) exhibited
a decrease in myofilament calcium sensitivity as shown by a
rightward shift of the force-pCa curve relative to WT cTnC
(pCa50 ¼ 5.9 6 0.10 vs. pCa50 ¼ 6.2 6 0.04; p , 0.05).
There was no significant difference in myofilament cooper-
ativity as judged by the Hill coefficient (n¼ 1.86 0.8 vs. n¼
1.9 6 0.07; p ¼ NS).
Calcium binding afﬁnity is decreased in
mutant TnC
We postulated that the observed contractile phenotypes were
directly attributable to mutation D75Y, which is located in
the regulatory Ca21-binding pocket II and thus was predicted
to alter TnCCa21-binding affinity. TnCCa21 binding affinity
was derived from Ca21 titration curves by measuring the
Ca21-induced increase in fluorescence intensity in IAANS-
labeled TnC. The fluorescence-pCa relationships were fitted
to a general Hill equation. In Fig. 6 B, TnC(E59D,D75Y) again
exhibited a rightward shift of the fluorescence-pCa curve rel-
ative to WT cTnC, indicative of a decrease in Ca21 binding
affinity (pCa50¼ 5.06 0.10 vs. pCa50¼ 5.46 0.05 p, 0.05).
D75Y mutation decreases functional concerted
motions in cNTnC
To further elucidate a detailed molecular mechanism under-
lying the reduced Ca21-binding affinity associated with
mutation D75Y, we carried out molecular dynamics (MD)
simulations on cNTnC (PDB entry: 1SPY) (22). Mutant
E59D was functionally irrelevant and was not included in the
computational analyses. The Asp75/Tyr mutation removes
negative charge, and was therefore expected to alter the
electrostatic interaction of the cNTnC structure. Interestingly,
the mutation also caused the side-chain of Tyr75 to point
toward helix N, and formed a van der Waals interaction with
Val9 (Fig. 7). The favorable van der Waals interaction be-
tween Tyr75 and helix N is approximately 3.3 kcal/mol
averaged along the MD trajectories, compared with less than
0.5 kcal/mol for the WT. MD simulations on the WT and
mutant D75Y showed no significant differences in root
mean-square deviation from the initial structure (Fig. 8 A).
Structural analysis along the MD trajectory also showed no
significant differences in secondary structure fluctuations,
except for helix N in mutant D75Y that seemed to be more
stable due presumably to the van der Waals contact between
Val9 and Tyr75 (Fig. 8 B).
From the normal mode analysis, we obtained the concerted
motions between the residues of the cNTnC structure. Con-
certed motions provide information on the regions within a
molecule that move in a correlated or anti-correlated manner,
and thus offer a more detailed accounting of conformational
changes important for protein function.WT cNTnC (Fig. 9 A)
exhibited significant concerted motions, notably anti-corre-
lated motions (0.4 to 1.0) between the helix A–b1 loop
(residues 25–32, Ca21-binding Site I) and the anti-parallel
b-sheet (b1: 35–37 and b2: 71–73), correlated motions be-
tween the two strands of the b-sheet, as well as between the
helix C–b2 loop (Ca21-binding Site II) and b1–helix B loop.
Importantly, the regulatory Ca21-binding loop II (residues
65–76) seems to be an active region for concerted motions
(Fig. 9 A). These concerted motions are considerably reduced
in the mutant D75Y (Fig. 9 B), suggesting an important role
FIGURE 4 Myofilament calcium responsiveness in permeabilized myocytes
at 4 days post-adenoviral infection. (A) Representative tracings of sarcomere
shortening in WT and TnC(E59D,D75Y) myocytes induced by a stepwise
increase in calcium concentration, expressed as pCa. After each pCa solution
change, the skinned myocyte was reperfused with relaxing solution (pCa 9)
until recovery of slack sarcomere length was obtained. (B) The sarcomere
length change-pCa relationships of WT and mutant TnC infected cardio-
myocytes. The myofilament calcium responsiveness of TnC(E59D,D75Y)
(triangle, n ¼ 9) and TnCD75Y (diamond, n ¼ 11) myocytes was markedly
blunted compared to WT (circle, n ¼ 9) or TnCE59D (square, n ¼ 9). Data
expressed as mean 6 SE. *p , 0.05 TnC(E59D,D75Y) and TnCD75Y versus
WT and TnCE59D by two-way ANOVA, Bonferroni post-hoc test.
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for concerted motions in loop II for Ca21-binding affinity.
Although we do not know the precise mechanism, one pos-
sible explanation is that the van der Waals interaction be-
tween Val9 and Tyr75 in the mutant sterically hinders the
motion of the b-sheet as well as its upstream and/or down-
stream loops including the Ca21-binding loop. We take these
data as evidence that a decrease in concerted motions in the
calcium regulatory domain of TnC directly interferes with the
calcium binding properties of TnC.
DISCUSSION
In this report, we describe functional and structural conse-
quences of two novel missense mutations in cardiac TnC
isolated from a patient diagnosed with idiopathic dilated
cardiomyopathy. We found that cardiomyocytes expressing
mutation D75Y, but not E59D, in TnC exhibited impaired
myocyte contractility, despite normal calcium transients, and
decreased myofilament calcium sensitivity. At the protein
level, Ca21-binding affinity was decreased inmutant TnC and
this is consistent with our computational analysis that show a
dramatic decrease in intramolecular concerted motions in the
regulatory Ca21-binding pocket of TnC. Our study provides
mechanistic insight into how a specific mutation directly al-
ters the dynamicmolecular microenvironment in TnC leading
to impairment of myofilament calcium signal transmission
with consequent cardiomyocyte contractile dysfunction.
Functional effects of TnC(E59D,D75Y)
Mutation D75Y, located in the regulatory Ca21-binding Site
II, is juxtaposed to the last calcium coordinating position and
FIGURE 5 TnC extraction and reconstitution in rabbit psoas fibers and force-pCa measurement. (A) Rabbit psoas fiber extracts before and after TnC
replacement were subjected to SDS-PAGE analysis. (Upper panel) 4–20% gel was stained with Coomassie, (lane 1) Purified cTnC, (lane 2) untreated control,
(lane 3) 12 min TnC extraction, (lane 4) 10 min reconstitution with cTnC (note: cTnC migrates ahead of sTnC). (Lower panel) 12.5% gel was silver-stained,
(lane 1) purified sTnC, (lane 2) 10 min reconstitution with sTnC, (lane 3) 5 min reconstitution with sTnC, (lane 4) 12 min TnC extraction, (lane 5) untreated
control. TnT, troponin T; Tm, tropomyosin; TnI, troponin I; sTnC, skeletal TnC; cTnC, cardiac TnC; LC1, LC2, and LC3 are myosin light chains 1, 2, and 3,
respectively. (B) Representative chart recording of force in a single skinned rabbit psoas fiber at various pCa solutions before endogenous sTnC extraction, after
extraction, and after reconstitution with native sTnC. The pCa values of the solutions are shown below the tracings. (C) The force-pCa relationships were obtained
from skinned rabbit psoas fibers after reconstitution with either native sTnC (open circle, n¼ 6), WT cTnC (gray circle, n¼ 8), or mutant TnC(E59D, D75Y) (black
triangle, n ¼ 8). All data were normalized to the average force value obtained at pCa 4.0 with sTnC reconstitution and the data expressed as mean 6 SE.
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thus was expected to interfere with normal calcium binding
of the coordinating residues. Mutation E59D is located in the
proximal helix flanking loop II (helix C), which has been
suggested to be important in ‘‘fine tuning’’ of calcium
binding to the regulatory site of TnC, as site-directed muta-
genesis of helix C in skeletal TnC was shown to decrease
calcium binding affinity (38). To determine the functional
effects of TnC(E59D,D75Y), as well as the individual TnC
mutations, we incorporated the TnC mutants into cardiac
myocytes, using the adenoviral methodology that has been
shown previously to be an efficient assay for robust incor-
poration of other recombinant myofilament proteins TnI,
TnT, and tropomyosin in cardiomyocytes (32,39,40). Im-
portantly, our assay resulted in targeted remodeling of TnC in
the troponin complex, without any alteration in the compo-
sition of other myofilament proteins or ultra-structural
changes in the sarcomeric lattice. Under these conditions, we
found a consistent and striking functional phenotype caused
by TnC(E59D,D75Y) with impaired cell contractility and im-
paired myofilament calcium responsiveness in intact and
permeabilized cells, respectively. Furthermore, the impaired
TnC(E59D,D75Y) phenotype was completely recapitulated by
mutation D75Y, whereas E59D seemed to be functionally
benign. The fact that intracellular calcium homeostasis was
not different between WT and mutant TnC groups, clearly
points to a defect at the level of the myofilaments, which was
confirmed in our force-pCa experiments showing a decrease
in myofilament Ca21-sensitivity in fixed-end psoas fibers
reconstituted with TnC(E59D,D75Y). We further go on to
show that the ability of the mutant TnC to bind Ca21 is al-
tered as Ca21-binding affinity in IAANS-labeled recombi-
nant TnC(E59D,D75Y) was decreased. An important aspect in
considering intracellular calcium homeostasis is the rapid
buffering of cytosolic calcium that is mediated in large part
by TnC (;60% of total cytoplasmic calcium buffering ca-
pacity) (41). A decrease in TnC(E59D,D75Y) calcium binding
affinity is expected to affect the rapid cytoplasmic calcium
buffering capacity that, in turn, could affect the intracellular
calcium transient, provided the calcium flux through the sar-
coplasmic reticulum (SR) and sarcolemma remain unchanged.
Intracellular calcium homeostasis, however, was unaffected
by either TnC(E59D,D75Y) or TnCD75Y incorporation into the
myofilaments, suggesting that normal calcium cycling was
maintained despite altered TnC(E59D,D75Y) calcium binding/
buffering. Further studies are needed to determine whether
normal calcium homeostasis was maintained as a result of
FIGURE 6 Force-pCa and fluorescence-pCa relationships. (A) Force-pCa
data after TnC reconstitution were normalized to the force obtained at pCa
4.0 and a modified Hill equation (see Materials and Methods) was fitted to
the data. (B) Fluorescence of IAANS-labeled recombinant TnC was titrated
with Ca21. The data was normalized to the fluorescence obtained at pCa 4.0,
and the Hill equation was fitted to the data. The fitted curves for the mean
data are shown, WT cTnC (gray) and mutant TnC(E59D,D75Y) (black).
FIGURE 7 Structure of the N terminus of cardiac TnC (PDB entry:
1SPY). The helices of TnC are labeled N and A–D and the b-strands are
labeled b1 and b2. Val9 and D/Y75 are shown explicitly using the ball-and-
stick model (color scheme is: C in gray, H in white, and O in red). The mean
minimum heavy-atom distance between D75 and V9 was ;6 A˚ in the WT
cNTnC simulation, whereas the distance dropped to 4.2 A˚ between Y75 and
V9 in the simulation of the mutant. The two Ca21-binding sites are labeled
as Site I and Site II. In the Ca21-saturated form, Ca21 binds to Site II
whereas Site I is empty.
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compensatory changes in other calcium-handling proteins
(e.g., Na1/Ca21 exchanger, SR Ca21-ATPase, ryanodine
receptors) to offset the decrease in TnC(E59D,D75Y) calcium
binding and/or buffering. Taken together, our findings show
a clear functional deficit in TnC(E59D,D75Y) and TnCD75Y
myocytes that was independent of intracellular calcium levels
and occurred at the level of the mutant TnC.
Molecular basis of TnCD75Y phenotype
It is well documented that in skeletal TnC, the regulatory
N domain switches from a ‘‘closed’’ to ‘‘open’’ state on
binding of two calcium ions, causing helices N, A, and D to
move as a unit away from helices B and C. This conforma-
tional switch exposes a hydrophobic cleft in TnC for binding
of skeletal TnI. By contrast, binding of calcium in the
N-terminus of cardiac TnC (cNTnC) causes minimal con-
formational change, and studies have shown that binding of a
C-terminal fragment of cardiac TnI (in a region spanning
residues 147–163) in the hydrophobic cleft is needed to in-
duce the fully ‘‘open’’ state in cNTnC (7,8). The canonical
motif in Ca21-binding proteins that permits Ca21 coordina-
tion is the EF-hand (helix–loop–helix), with the 12-residue
loop containing three negatively charged acid pairs at posi-
tions 1 (1x) and 9 (x), 3 (1y) and 7 (y) and 5 (1z) and 12
(z) that bind Ca21 (10). The acid pairs form a quasi-planar
pentagon structure that coordinate Ca21 and mutational
analysis of the EF-hand protein, calmodulin, has shown that
the acid pairs increase Ca21 affinity by increasing the rate
of Ca21 association (42). In our study, the D75Y mutation,
juxtaposed to the z coordinating position, removes a neg-
atively charged residue from Ca21-binding Site II and this
change in electrostatic long-range interaction could alter the
kinetics of Ca21-exchange. Decreasing the negative charge
in the Ca21-binding loop by replacement of the Asp75 with
Tyr is expected to decrease the Ca21 association rate, even if
the residue is not in a Ca21 coordinating position, leading
ultimately to decreased TnC Ca21 affinity as observed for the
D75Y mutant. Thus, mutation D75Y may have induced a
structural modification in the regulatory ‘‘closed’’ domain of
TnC that could have obstructed calcium binding, thus re-
sulting in a diminished trigger for initiating actin-myosin
interaction at any given calcium concentration. To further
address this central question, we carried out molecular dy-
namics simulations using the published Ca21-free TnC
structure (22). It should be noted that although there have
been extensive studies on the static structure and biochemical
properties of TnC, no study has looked at the dynamic cor-
related motions of this protein. Subject to limitations in
sampling time and computational molecular approximations,
molecular dynamics has been shown to provide detailed in-
formation regarding conformational changes in a protein.
Our analysis showed that even though the mutant Tyr75
residue did not seem to directly interfere with calcium co-
ordination as it was pointed away from the Ca21-binding
pocket, it introduced a new hydrophobic interaction between
Tyr75 and Val9 not present in the wild-type (Fig. 7). Inter-
estingly, our simulations showed no obvious global structural
perturbations with the introduction of Tyr75 in TnC. Anal-
ysis of concerted motions showed the presence of correlated
and anti-correlated motions in Ca21-binding Site II of WT
TnC that were reduced significantly by the D75Y mutation.
We interpret this as evidence that the molecular concerted
motions of cNTnC (greatly facilitated by the negative Asp75
charge of the loop), is important in establishing the Ca21
binding kinetics of cTnC. Removal of the negative charge
and/or introduction of the Tyr75/Val9 hydrophobic interac-
tion in the D75Y mutant reduces the extent of concerted
motions in cNTnC, which we predict will interfere with the
Ca21 on-rate, and thus impair Ca21 binding affinity. Lehrer
and Geeves (43) and McKillop and Geeves (44) have pro-
posed a three-state model for thin filament activation and
suggested that Ca21 binding to TnC shifts the equilibrium of
thin filament states from the ‘blocked’ to the ‘closed’ state,
and the development of strong crossbridges further shifting
the ‘closed’ to the ‘open’ state. In this context, our results
would suggest that mutant D75Y limits the transition from
FIGURE 8 Computational analysis of the Ca21-free form of cNTnC. (A)
Root mean-square deviation (RMSD) showed relatively stable structures for
both WT and mutant D75Y. (B) Secondary structure analysis along the
molecular dynamics trajectory of Ca21-free cNTnC. The secondary structure
assignment of helices N and A–D are labeled at the top of the graphs. A plus
sign denotes the helical conformation, whereas the blank spaces represent
nonhelical conformations. Results for WT (left panel) and mutant D75Y
(right panel) show similarity between the helical conformations except that
helix N is more stable in mutant D75Y.
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the ‘blocked’ to the ‘closed’ state, thereby diminishing the
probability of movement to the ‘open’ state and thus reducing
force generation.
Even though our experimental and simulation data strongly
suggest an impairment in Ca21-binding affinity of mutant
TnC, bear in mind that TnC does not function in isolation but
as part of an integrated contractile system. Both TnI and TnT,
and more recently myosin have been shown to influence the
Ca21-binding properties of TnC (5,45). This Ca21-depen-
dent interplay between TnC and the other myofilament pro-
teins may lead to a mechanism whereby the calcium-bound
mutant TnC alters downstream myofilament interactions that
in turn ‘‘negatively’’ feeds back on TnC Ca21-binding af-
finity. Our data, however, seems to dispute this notion as
myofilament cooperativity (as judged by the Hill coefficient
in the force-pCa experiments) was not altered by mutant
TnC. Thus, our results strongly implicate impaired Ca21-
binding affinity of mutant TnC as a primary event in
TnC(E59D,D75Y) myocyte contractile dysfunction.
Implications for disease
A growing body of evidence has implicated myofilament
mutations as primary causes of myocardial disorders, and
mutations in b-myosin heavy chain, troponin T, tropomyo-
sin, actin, and titin have all been associated with familial
dilated cardiomyopathy (46). It is important to emphasize
that the TnC mutations characterized in the current investi-
gation were identified from left ventricular tissue obtained
from a single patient diagnosed with idiopathic dilated cardio-
myopathy. Regrettably, it was not possible for us to retrieve
the patient’s medical records or procure any DNA from the
patient for confirmation of the TnC mutations by genotyping.
Repeated RNA analyses from different sections of the tissue
sample, however, yielded the same result that makes it
unlikely that the reported TnC mutations represent cloning
artifacts. We also recognize that linkage analyses or co-
segregation studies are necessary to fully elucidate whether
the mutant TnC characterized in this study is indeed a causal
disease gene for dilated cardiomyopathy. Recently, a missense
FIGURE 9 Concerted motions calculated from the
500 largest vibrational modes from WT and mutant
Ca21-free cNTnC. The secondary structure assign-
ment is labeled at the top and side. Residues within
the same helical region have the highest correlated
motion, as shown by diagonal red dots in both WT
and mutant (note the diagonal symmetry of the
graphs). (A) WT exhibited significant anti-correlated
(between the helix A – b1 loop, (residues 25–32) and
b-sheet (35–37 and 71–73)) and correlated motions
(between the two strands of b-sheet as well as the
helix C–b2 loop and the b1–helix B loop). Circle
denotes concerted motions in the Ca21-binding
pocket. The corresponding ribbon structure of the
WT cTnC (PDB entry: 1SPY) with the off-diagonal
mapped concerted motions is shown to the right. The
anti-correlated motion is between the blue region
(residues 25–32) and the red regions, whereas the
correlated motions are between the red regions. (B)
The extent of concerted motions is dramatically
reduced in the D75Y mutant as shown by the sec-
ondary structure assignment and the corresponding
mutant ribbon structure.
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mutation (G159D) in TnC was identified in a family with
inherited dilated cardiomyopathy (47). The mutation was
located in the C-terminal lobe of troponin C, considered to be
the anchoring domain of TnC to the troponin complex, and
showed altered intertroponin interactions, in vitro. Two re-
cent articles scrutinized more closely the G159D TnC mu-
tation and showed that although the force-pCa relationship
was unaffected, the mutation decreased the rate of force
production in reconstituted skinned fibers (48) and blunted
the TnI phosphorylation induced decrease in Ca21-sensitive
tension development (49). These recent reports are signifi-
cant as they challenge a commonly held notion that myofil-
ament mutations associated with dilated cardiomyopathy
converge on a final common pathway leading to reduced
myofilament Ca21 sensitivity (50). Whatever the mecha-
nism, our study and those by others, identify TnC as another
candidate gene in the growing list of sarcomere gene muta-
tions linked with dilated cardiomyopathy.
SUMMARY AND CONCLUSIONS
Our findings showed a disruption in concerted motions in the
regulatory domain of mutant D75Y TnC, which we postulate
to be a mechanism underlying the decrease in myofilament
calcium sensitivity and impaired contractility in cardio-
myocytes expressing mutant TnC. The observed cellular
dysfunction in cardiomyocytes expressing mutant D75Y
TnC recapitulates many of the dysfunctional features of di-
lated cardiomyopathy. Although it is not entirely clear how a
primary defect in TnC calcium binding affinity leads to ab-
errant ventricular remodeling, a decrease in systolic function
would contribute significantly to compensatory responses in
an effort to maintain cardiac output. These include elevated
end-diastolic volumes, which result in significant increases in
wall stress at any given pressure with adverse consequences
for cell survival, triggering a cycle of maladaptive events
characterized by progressive ventricular dilatation. Conges-
tive heart failure is often associated with desensitization of
the myocardium to calcium. Understanding the molecular
mechanisms that regulate TnC calcium binding and signal
transmission could therefore lead to the design of calcium
sensitizing agents useful in the treatment of heart failure.
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